Comparison between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial

Comparison between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial

Objective: Several studies have shown that closed-loop automated insulin delivery (the artificial pancreas) improves glucose control compared with sensor-augmented pump therapy. We aimed to confirm these findings using our automated insulin delivery system based on the iPancreas platform. Research D...

Full description

Bibliographic Details
Main Authors: El-Fathi, A. (Author), Gouchie-Provencher, N. (Author), Haidar, A. (Author), Jacobs, P.G (Author), Legault, L. (Author), Messier, V. (Author), Rabasa-Lhoret, R. (Author), Raffray, M. (Author), Rutkowski, J. (Author)
Format: Article
Language:English
Published: Mary Ann Liebert Inc. 2021
Subjects:
adult
Adult
aged
antidiabetic agent
Article
artificial pancreas
Artificial pancreas
Blood Glucose
clinical article
Closed-loop
comparative study
controlled study
crossover procedure
Cross-Over Studies
Diabetes Mellitus, Type 1
diabetic ketoacidosis
dose calculation algorithm
female
glucose blood level
hemoglobin A1c
human
Humans
hypoglycemia
Hypoglycemic Agents
insulin
Insulin
insulin dependent diabetes mellitus
insulin infusion
Insulin Infusion Systems
male
model predictive control
multicenter study
outcome assessment
Pancreas, Artificial
priority journal
randomized controlled trial
Randomized-controlled trial
Sensor-augmented pump therapy
treatment outcome
Treatment Outcome
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items